
|Podcasts|November 7, 2019
Episode 43: Pharma Reputation
Author(s)Christen Harm, Elaine Quilici
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
Advertisement
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis Investors Share Concerns Over M&A Strategy: Report
2
The Agentic AI Revolution in Biopharma
3
How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications
4
Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum
5

